Coloplast A/S B Stock
Coloplast A/S B Stock price
Key metrics
Is Coloplast A/S B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
Coloplast A/S B Stock Analysis
Analyst Opinions
27 Analysts have issued a Coloplast A/S B forecast:
Analyst Opinions
27 Analysts have issued a Coloplast A/S B forecast:
Financial data from Coloplast A/S B
| Jun '25 |
+/-
%
|
||
| Revenue | 27,867 27,867 |
6%
6%
|
|
| Gross Profit | 18,823 18,823 |
6%
6%
|
|
| EBITDA | 8,871 8,871 |
5%
5%
|
EBIT (Operating Income) EBIT | 7,521 7,521 |
5%
5%
|
| Net Profit | 4,075 4,075 |
18%
18%
|
|
In millions DKK.
Don't miss a Thing! We will send you all news about Coloplast A/S B directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
| Head office | Denmark |
| CEO | Lars Rasmussen |
| Employees | 16,628 |
| Founded | 1957 |
| Website | www.coloplast.dk |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
